The HER2/RNaseP allele ratio was 5.2 in the laser-microdissected tumor cells, similar to the 5.3 ratio in the HER2-overexpressing breast cancer cell line BT-474 (Figure 1B). The gene discussed is ERBB2; the disease is breast carcinoma.